Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 20,000 shares at $3.49 ($70K) on 2025-11-21, disclosed to the SEC on 2025-11-21.
Open-market purchase of $70k ANVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.49 | 10,000 | $35K | 49.9% |
| 2 | $3.50 | 10,000 | $35K | 50.1% |
| Total | $3.50 avg | 20,000 | $70K | 100% |
| Filing → |
| ANVS | BUY | 2025-12-08 | $194K | — | Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-18 | $32K | — | Filing → |